Please assess the completion status of the following clinical trial:

Trial Title: Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Main Inclusion Criteria:~1. Healthy volunteers aged between 18 to 50 years.~2. Body mass index (BMI) between 18 and 30 kg/m2.~3. Female subjects must:~   * be of childbearing potential with a negative serum β-human chorionic gonadotropin (β-HCG) test at screening, and be willing and able to use medically acceptable double barrier methods of birth control, throughout the whole study; or~  * be postmenopausal; or~  * have received surgical sterilisation at least 6 months before screening; AND~  * females must not be receiving hormone replacement therapy (HRT).~Main exclusion Criteria:~1. Abnormal QTcF and/or heart rate/blood pressure values at baseline.~2. Subjects with ECG abnormalities that may interfere with the accurate assessment of the QT interval.~3. Subjects with known cardiovascular disorders.~4. Subjects with known clinically significant arrhythmias.~5. Subjects with risk factors e.g., Torsades de Pointes.~6. Subjects with clinically relevant, abnormal serum electrolytes or complete blood count (CBC) at screening.~7. Female subjects who are lactating or pregnant.~8. Subjects suffering from other significant medical conditions.~9. Subjects with a known allergy or sensitivity to moxifloxacin, or to prucalopride.~10. Subjects with a positive screening test for hepatitis B, hepatitis C, or HIV at screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Prucalopride
- 2 (Type: PLACEBO_COMPARATOR): Placebo/moxifloxacin

Based on this trial design, predict the completion outcome and termination type (if applicable).